Invoking a Right to Try in Regenerative Medicine
Scholars caution against using the Right to Try Act to skirt regulation for regenerative therapies.
FDA Reform Needs to Look More Like Tax Reform
U.S. regulators should model the medical device classification process on recent tax reform.
Cities on the Forefront of Public Health Regulation
Scholar examines ways that local governments are combating issues like obesity and asthma.
How to Better Regulate Payments to Research Participants
Experts say federal agencies must clarify rules permitting payment to research subjects.
Working for Welfare Not Faring Well?
Analysts debate the effectiveness of work requirements for recipients of cash assistance in Kansas.
How Regulation Can Improve Surgery
Scholar argues that agencies should collect evidence on surgical procedures to help implement best practices.
Gene Editing of Human Embryos Prompts Calls For Regulation
Despite ethical concerns, scholar argues that gene editing of human embryos should not be banned.
How Much of an Income Drop Will Take a Life?
Policymakers should consider the impact of their decisions on not just wealth, but also human life.
Yams v. Sweet Potatoes
Thanksgiving offers chance to explore scientific and regulatory distinctions in popular holiday fare.
How FDA Should Use Its Authority to Regulate Human Cells
FDA should encourage states to be the primary regulators of stem cell procedures.
Curbing Prescription Opioid Abuse Through Insurance Regulation
New study shows regulators have overlooked insurers in tackling the opioid epidemic.
FDA’s Authority to Regulate Off-Label Promotion
Expert argues that federal law gives regulator authority to restrict unauthorized drug uses.